PCSK9 inhibition: current concepts and lessons from human genetics.

about

ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.

P2860

Q40104818-FFDF25EC-E456-4F0D-83B4-2AA8EF93AF46

P2860

PCSK9 inhibition: current concepts and lessons from human genetics.

Item

http://www.wikidata.org/entity/Q38338236

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

PCSK9 inhibition: current concepts and lessons from human genetics.

@en

type

Item

label

PCSK9 inhibition: current concepts and lessons from human genetics.

@en

prefLabel

PCSK9 inhibition: current concepts and lessons from human genetics.

@en

P1476

PCSK9 inhibition: current concepts and lessons from human genetics.

@en

P2093

Fatima Rodriguez

http://www.w3.org/2001/XMLSchema#string

Joshua W Knowles

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation

Lipoprotein(a) as a cardiovascular risk factor: current status

Inhibition of PCSK9: a powerful weapon for achieving ideal LDL cholesterol levels

A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

P2888

s11883-015-0487-8

P304

487

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11883-015-0487-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1024405659

http://www.w3.org/2001/XMLSchema#string

P698

25637042

http://www.w3.org/2001/XMLSchema#string

PCSK9 inhibition: current concepts and lessons from human genetics.

about

P2860

P2860

PCSK9 inhibition: current concepts and lessons from human genetics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698